Jing Huang

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Diffusion Weighted

Epidermal Growth Factor Receptor

Pseudomonas Aeruginosa

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Peng Guo, Jing Huang, Bing Zhu, Andrew C Huang, Lingxiao Jiang, Jianmin Fang, Marsha A Moses
A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Science advances 9 (18) (2023)
Peng Guo, Jing Huang, Bing Zhu, Andrew C Huang, Lingxiao Jiang, Jianmin Fang, Marsha A Moses
A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Science advances 9 (18) (2023)
Peng Guo, Jing Huang, Bing Zhu, Andrew C Huang, Lingxiao Jiang, Jianmin Fang, Marsha A Moses
A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Science advances 9 (18) (2023)
Peng Guo, Jing Huang, Bing Zhu, Andrew C Huang, Lingxiao Jiang, Jianmin Fang, Marsha A Moses
A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Science advances 9 (18) (2023)
Peng Guo, Jiang Yang, Daxing Liu, Lan Huang, Gillian Fell, Jing Huang, Marsha A Moses, Debra T Auguste
Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis. Science advances 5 (3) (2019)